Augmentin 400 mg + 57 mg/5 ml prašak za oralnu suspenziju s okusom voća
| Name | Augmentin 400 mg + 57 mg/5 ml prašak za oralnu suspenziju s okusom voća |
|---|---|
| Marketing Authorisation Number | HR-H-377920132 |
| Active Substance | amoksicilin trihidrat kalijev klavulanat |
| Composition | nakon rekonstitucije, svaki ml oralne suspenzije sadrži amoksicilin trihidrat što odgovara 80 mg amoksicilina i kalijev klavulanat što odgovara 11,4 mg klavulanske kiseline |
| Pharmaceutical Form | prašak za oralnu suspenziju |
| Manufacturer | Glaxo Wellcome Production, Mayenne cedex, Francuska |
| Marketing Authorisation Holder | GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date | 20.08.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/18-02/215 |
| Registration Number | 381-12-01/70-21-22 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for non-renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J01CR02 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
